We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+2.59%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.91B
AUM Growth
-$2.79M
Cap. Flow
-$27.2M
Cap. Flow %
-0.93%
Top 10 Hldgs %
20.73%
Holding
3,310
New
248
Increased
388
Reduced
954
Closed
189

Top Buys

Rank Stock Value
1
FPE icon
First Trust Preferred Securities and Income ETF
FPE
+$6.56M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$3.36M
3
ILMN icon
Illumina
ILMN
+$3.21M
4
IVV icon
iShares Core S&P 500 ETF
IVV
+$3M
5
RBA icon
RB Global
RBA
+$2.93M

Top Sells

Rank Stock Value
1
PFFD icon
Global X US Preferred ETF
PFFD
+$5.94M
2
VST icon
Vistra
VST
+$5.92M
3
GDDY icon
GoDaddy
GDDY
+$5M
4
SMCI icon
Super Micro Computer
SMCI
+$4.37M
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$4M

Sector Composition

Rank Sector Weight
1 Technology 21.86%
2 Industrials 10.11%
3 Consumer Discretionary 9.49%
4 Financials 8.92%
5 Healthcare 8.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRSN icon
1401
VeriSign
VRSN
$25.6B
$162K 0.01%
912
-75
-8% -$13.4K
MAS icon
1402
Masco
MAS
$14.7B
$162K 0.01%
2,423
-177
-7% -$12.5K
LMAT icon
1403
LeMaitre Vascular
LMAT
$1.87B
$161K 0.01%
1,962
– –
SNDX icon
1404
Syndax Pharmaceuticals
SNDX
$1.77B
$161K 0.01%
7,858
– –
ARRY icon
1405
Array Technologies
ARRY
$796M
$161K 0.01%
15,690
– –
LZB icon
1406
La-Z-Boy
LZB
$1.64B
$161K 0.01%
4,316
– –
CHCO icon
1407
City Holding Co
CHCO
$2.08B
$161K 0.01%
1,513
– –
FCAL icon
1408
First Trust California Municipal High income ETF
FCAL
$221M
$161K 0.01%
3,246
+200
+7% +$9.87K
WSBC icon
1409
WesBanco
WSBC
$4.1B
$160K 0.01%
5,737
– –
NTB icon
1410
Bank of N.T. Butterfield & Son
NTB
$2.5B
$160K 0.01%
4,557
-426
-9% -$14.3K
WGO icon
1411
Winnebago Industries
WGO
$915M
$160K 0.01%
2,950
– –
ENVA icon
1412
Enova International
ENVA
$6.52B
$160K 0.01%
2,566
-263
-9% -$16K
AMPH icon
1413
Amphastar Pharmaceuticals
AMPH
$858M
$159K 0.01%
3,987
– –
BG icon
1414
Bunge Global
BG
$21.5B
$159K 0.01%
1,490
-124
-8% -$13K
SFL icon
1415
SFL Corp
SFL
$1.57B
$159K 0.01%
11,446
– –
ANDE icon
1416
Andersons Inc
ANDE
$2.21B
$159K 0.01%
3,200
– –
MXL icon
1417
MaxLinear
MXL
$6.95B
$159K 0.01%
7,878
– –
WKC icon
1418
World Kinect Corp
WKC
$1.89B
$158K 0.01%
6,132
– –
CTS icon
1419
CTS Corp
CTS
$1.82B
$158K 0.01%
3,118
– –
DHT icon
1420
DHT Holdings
DHT
$3.09B
$158K 0.01%
13,636
– –
IP icon
1421
International Paper
IP
$21.8B
$158K 0.01%
3,655
-338
-8% -$13.7K
DAN icon
1422
Dana Inc
DAN
$3.26B
$157K 0.01%
12,963
– –
AMCR icon
1423
Amcor
AMCR
$21.4B
$157K 0.01%
3,212
– –
VCYT icon
1424
Veracyte
VCYT
$3.59B
$157K 0.01%
7,233
– –
DO
1425
DELISTED
Diamond Offshore Drilling, Inc.
DO
$157K 0.01%
10,114
– –
55 56
57
58 59

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Ameritas Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Ameritas Investment Partners held 3,310 positions worth $2.91B, down 0.1% from $2.92B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Ameritas Investment Partners's Q2 2024 filing shows 248 new, 388 increased, 954 reduced and 189 closed positions. Its largest new stake was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M. The largest sale was Global X US Preferred ETF, an estimated $5.94M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2024 buy was BioMarin Pharmaceuticals: 40,387 shares worth $3.33M.
  • Ameritas Investment Partners added most to First Trust Preferred Securities and Income ETF in Q2 2024, an estimated $6.56M increase.
  • Ameritas Investment Partners's biggest Q2 2024 reduction was Global X US Preferred ETF, cutting an estimated $5.94M.
  • Ameritas Investment Partners fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $2.65M.
  • Ameritas Investment Partners's ten largest holdings make up 21% of its $2.91B portfolio in Q2 2024.
  • Ameritas Investment Partners opened 248 new positions and closed 189 in Q2 2024.
  • Ameritas Investment Partners's portfolio value fell 0.1% quarter-over-quarter to $2.91B.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.